The mass-action law based algorithms for quantitative econo-green bio-research

被引:49
作者
Chou, Ting-Chao [1 ]
机构
[1] Mem Sloan Kettering Canc Ctr, Preclin Pharmacol Core Lab, Mol Pharmacol & Chem Program, New York, NY 10065 USA
关键词
HUMAN TUMOR XENOGRAFTS; DOSE-EFFECT RELATIONSHIPS; DRUG-COMBINATION; NUDE-MICE; DESOXYEPOTHILONE-B; MICHAELIS-MENTEN; COMPUTERIZED SIMULATION; EXPERIMENTAL-DESIGN; KINETIC SYSTEMS; STEADY-STATE;
D O I
10.1039/c0ib00130a
中图分类号
Q2 [细胞生物学];
学科分类号
071013 [干细胞生物学];
摘要
The relationship between dose and effect is not random, but rather governed by the unified theory based on the median-effect equation (MEE) of the mass-action law. Rearrangement of MEE yields the mathematical form of the Michaelis-Menten, Hill, Henderson-Hasselbalch and Scatchard equations of biochemistry and biophysics, and the median-effect plot allows linearization of all dose-effect curves regardless of potency and shape. The "median'' is the universal common-link and reference-point for the 1st-order to higher-order dynamics, and from single-entities to multiple-entities and thus, it allows the all for one and one for all unity theory to "integrate'' simple and complex systems. Its applications include the construction of a dose-effect curve with a theoretical minimum of only two data points if they are accurately determined; quantification of synergism or antagonism at all dose and effect levels; the low-dose risk assessment for carcinogens, toxic substances or radiation; and the determination of competitiveness and exclusivity for receptor binding. Since the MEE algorithm allows the reduced requirement of the number of data points for small size experimentation, and yields quantitative bioinformatics, it points to the deterministic, efficient, low-cost biomedical research and drug discovery, and ethical planning for clinical trials. It is concluded that the contemporary biomedical sciences would greatly benefit from the mass-action law based "Green Revolution''.
引用
收藏
页码:548 / 559
页数:12
相关论文
共 38 条
[1]
BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
[2]
Chou J., 1988, Pharmacologist, V30, pA231
[3]
Chou J. H., 1989, DOSE EFFECT ANAL MIC
[4]
Chou T., 1987, NEW AVENUES DEV CANC, V8, P37
[5]
Chou T.C., 1997, CalcuSyn for Windows: multiple-drug dose-effect analyzer and manual
[6]
Chou T.C., 1991, MEDIAN EFFECT PRINCI
[8]
DETERMINATION OF AVAILABILITY OF LIGAND-BINDING SITE AT STEADY-STATE FOR TOPOLOGICAL ASSESSMENT OF RECEPTORS WITH THE AID OF MICROCOMPUTERS [J].
CHOU, TC ;
CHOU, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1990, 183 (03) :921-921
[9]
DETERMINATION OF AVAILABILITY OF LIGAND-BINDING SITES IN STEADY-STATE SYSTEMS [J].
CHOU, TC .
JOURNAL OF THEORETICAL BIOLOGY, 1977, 65 (02) :345-356
[10]
Therapeutic cure against human tumor xenografts in nude mice by a microtubule stabilization agent, fludelone, via parenteral or oral route [J].
Chou, TC ;
Dong, HJ ;
Zhang, XG ;
Tong, WP ;
Danishefsky, SJ .
CANCER RESEARCH, 2005, 65 (20) :9445-9454